Feb 13 (Reuters) - German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on jabs to prevent malaria and influenza.



Latest News

USA Today: Maryland takes final shot at bowl eligibility vs Penn State

USA Today: Wisconsin RB Jonathan Taylor toughs it out

USA Today: Chiefs served lesson by Rams for playoffs: Clean up errors or risk another early exit

USA Today: NYPD: 'No credible threat' on Thanksgiving parade

USA Today: How a Pac-12 football team's mustache mania and a town's festival nearly broke NCAA rules

CBC: Federal Tory plan for gun laws LIVE

BBC: Stalker made fake 'sex' dating profiles of his Norfolk victim

Daily Mail: Loyal dog guards a dead friend in the snow after it was killed by a car

Daily Mail: Shoppers clamber over shelves to grab bargain TVs after Walmart worker accidentally priced them

ABC: WATCH: Thanksgiving's most disliked dishes

ABC: Iraq says airstrikes kill 40 Islamic State fighters in Syria

ABC: Malaria progress stalls, new report says

CNBC: Navient sinks 9.5% after audit suggests company deceived borrowers into higher-cost plans: AP

CTV News: U.S. sounds word of caution on expansion of Korea ties

Reuters: U.N. environment chief quits over travel expense report

WashingtonPost: He raped a teenager as she was dying of an overdose. His sentence: 34 months.

WashingtonPost: D.C. man found guilty in fatal 2016 shooting

WashingtonPost: Man is accused of killing his girlfriend’s former boyfriend

WashingtonPost: Enter your forecast for how much snow will fall in D.C. this winter

WashingtonPost: Thip Khao, Donburi and other D.C. food businesses to take over Isabella Eatery space in Tysons

WashingtonPost: Colt McCoy on starting for Redskins: ‘I certainly don’t take this for granted’

FOX: Woman who died on Princess Cruises ship did not want to go on trip, her children say

USA Today: Dead whale washed ashore with 13 pounds of plastic in its stomach